APO RESEARCH · REPORT
Omega-3 PUFA
Omega-3 PUFA, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Product & engineering
Understand the product.
Omega-3 PUFA, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
Selected research
Industry Research
Omega-3 PUFA Industry Research Report 2026
Market perspective
Omega-3 PUFA, also called ω-3 fatty acids or n-3 fatty acids, are polyunsaturated fatty acids (PUFAs) with a double bond (C=C) at the third carbon atom from the end of the carbon chain. Three types of omega-3 PUFA involved in human physiology are α-linolenic acid (ALA) (found in plant oils), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (both commonly found in marine oils). They are considered essential fatty acids and necessary for human health but the body can’t make them. Also they play a role in brain health as well as normal growth and development.
The major players in global Omega-3 PUFA market include DSM, BASF, Golden Omega, etc. The top 3 players occupy about 30% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Fish Oil Type is the main type, with a share over 80%. Dietary Supplements is the main application, which holds a share about 60%.
Report Scope
Read the full market overview
This report quantifies the global Omega-3 PUFA market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Omega-3 PUFA Market by Company
DSM
BASF
EPAX
Golden Omega
TASA
Omega Protein
Croda
KD Pharma(Marine Ingredients)
GC Rieber
Polaris
Auqi
Kinomega
Skuny
Xinzhou
Anti-Cancer
Sinomega
Omega-3 PUFA Segment by Type
Fish Oil Type
Linseed Oil Type
Algae Oil Type
Other Type
Omega-3 PUFA Segment by Application
Dietary Supplements
Functional F&B
Pharmaceuticals
Infant Formula
Others Field
Omega-3 PUFA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega-3 PUFA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omega-3 PUFA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega-3 PUFA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Omega-3 PUFA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Omega-3 PUFA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Omega-3 PUFA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fish Oil Type
- Linseed Oil Type
- Algae Oil Type
- Other Type
Applications
- Dietary Supplements
- Functional F&B
- Pharmaceuticals
- Infant Formula
- Others Field
Companies covered
- DSM
- BASF
- EPAX
- Golden Omega
- TASA
- Omega Protein
- Croda
- KD Pharma(Marine Ingredients)
- GC Rieber
- Polaris
- Auqi
- Kinomega
- Skuny
- Xinzhou
- Anti-Cancer
- Sinomega
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Omega-3 PUFA Market Size (2021-2032)
- 2.2.2 Global Omega-3 PUFA Sales (2021-2032)
- 2.2.3 Global Omega-3 PUFA Market Average Price (2021-2032)
- 2.3 Omega-3 PUFA by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Fish Oil Type
- 2.3.3 Linseed Oil Type
- 2.3.4 Algae Oil Type
- 2.3.5 Other Type
- 2.4 Omega-3 PUFA by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Dietary Supplements
- 2.4.3 Functional F&B
- 2.4.4 Pharmaceuticals
- 2.4.5 Infant Formula
- 2.4.6 Others Field
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Omega-3 PUFA Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Omega-3 PUFA Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Omega-3 PUFA Revenue of Manufacturers (2021-2026)
- 3.4 Global Omega-3 PUFA Average Price by Manufacturers (2021-2026)
- 3.5 Global Omega-3 PUFA Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Omega-3 PUFA, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Omega-3 PUFA, Product Type & Application
- 3.8 Global Manufacturers of Omega-3 PUFA, Established Date
- 3.9 Global Omega-3 PUFA Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DSM
- 4.1.1 DSM Company Information
- 4.1.2 DSM Business Overview
- 4.1.3 DSM Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DSM Omega-3 PUFA Product Portfolio
- 4.1.5 DSM Recent Developments
- 4.2 BASF
- 4.2.1 BASF Company Information
- 4.2.2 BASF Business Overview
- 4.2.3 BASF Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BASF Omega-3 PUFA Product Portfolio
- 4.2.5 BASF Recent Developments
- 4.3 EPAX
- 4.3.1 EPAX Company Information
- 4.3.2 EPAX Business Overview
- 4.3.3 EPAX Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 EPAX Omega-3 PUFA Product Portfolio
- 4.3.5 EPAX Recent Developments
- 4.4 Golden Omega
- 4.4.1 Golden Omega Company Information
- 4.4.2 Golden Omega Business Overview
- 4.4.3 Golden Omega Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Golden Omega Omega-3 PUFA Product Portfolio
- 4.4.5 Golden Omega Recent Developments
- 4.5 TASA
- 4.5.1 TASA Company Information
- 4.5.2 TASA Business Overview
- 4.5.3 TASA Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TASA Omega-3 PUFA Product Portfolio
- 4.5.5 TASA Recent Developments
- 4.6 Omega Protein
- 4.6.1 Omega Protein Company Information
- 4.6.2 Omega Protein Business Overview
- 4.6.3 Omega Protein Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Omega Protein Omega-3 PUFA Product Portfolio
- 4.6.5 Omega Protein Recent Developments
- 4.7 Croda
- 4.7.1 Croda Company Information
- 4.7.2 Croda Business Overview
- 4.7.3 Croda Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Croda Omega-3 PUFA Product Portfolio
- 4.7.5 Croda Recent Developments
- 4.8 KD Pharma(Marine Ingredients)
- 4.8.1 KD Pharma(Marine Ingredients) Company Information
- 4.8.2 KD Pharma(Marine Ingredients) Business Overview
- 4.8.3 KD Pharma(Marine Ingredients) Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 KD Pharma(Marine Ingredients) Omega-3 PUFA Product Portfolio
- 4.8.5 KD Pharma(Marine Ingredients) Recent Developments
- 4.9 GC Rieber
- 4.9.1 GC Rieber Company Information
- 4.9.2 GC Rieber Business Overview
- 4.9.3 GC Rieber Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GC Rieber Omega-3 PUFA Product Portfolio
- 4.9.5 GC Rieber Recent Developments
- 4.10 Polaris
- 4.10.1 Polaris Company Information
- 4.10.2 Polaris Business Overview
- 4.10.3 Polaris Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Polaris Omega-3 PUFA Product Portfolio
- 4.10.5 Polaris Recent Developments
- 4.11 Auqi
- 4.11.1 Auqi Company Information
- 4.11.2 Auqi Business Overview
- 4.11.3 Auqi Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Auqi Omega-3 PUFA Product Portfolio
- 4.11.5 Auqi Recent Developments
- 4.12 Kinomega
- 4.12.1 Kinomega Company Information
- 4.12.2 Kinomega Business Overview
- 4.12.3 Kinomega Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Kinomega Omega-3 PUFA Product Portfolio
- 4.12.5 Kinomega Recent Developments
- 4.13 Skuny
- 4.13.1 Skuny Company Information
- 4.13.2 Skuny Business Overview
- 4.13.3 Skuny Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Skuny Omega-3 PUFA Product Portfolio
- 4.13.5 Skuny Recent Developments
- 4.14 Xinzhou
- 4.14.1 Xinzhou Company Information
- 4.14.2 Xinzhou Business Overview
- 4.14.3 Xinzhou Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Xinzhou Omega-3 PUFA Product Portfolio
- 4.14.5 Xinzhou Recent Developments
- 4.15 Anti-Cancer
- 4.15.1 Anti-Cancer Company Information
- 4.15.2 Anti-Cancer Business Overview
- 4.15.3 Anti-Cancer Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Anti-Cancer Omega-3 PUFA Product Portfolio
- 4.15.5 Anti-Cancer Recent Developments
- 4.16 Sinomega
- 4.16.1 Sinomega Company Information
- 4.16.2 Sinomega Business Overview
- 4.16.3 Sinomega Omega-3 PUFA Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Sinomega Omega-3 PUFA Product Portfolio
- 4.16.5 Sinomega Recent Developments
5 Global Omega-3 PUFA Market Scenario by Region
- 5.1 Global Omega-3 PUFA Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Omega-3 PUFA Sales by Region: 2021-2032
- 5.2.1 Global Omega-3 PUFA Sales by Region: 2021-2026
- 5.2.2 Global Omega-3 PUFA Sales by Region: 2027-2032
- 5.3 Global Omega-3 PUFA Revenue by Region: 2021-2032
- 5.3.1 Global Omega-3 PUFA Revenue by Region: 2021-2026
- 5.3.2 Global Omega-3 PUFA Revenue by Region: 2027-2032
- 5.4 North America Omega-3 PUFA Market Facts & Figures by Country
- 5.4.1 North America Omega-3 PUFA Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Omega-3 PUFA Sales by Country (2021-2032)
- 5.4.3 North America Omega-3 PUFA Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Omega-3 PUFA Market Facts & Figures by Country
- 5.5.1 Europe Omega-3 PUFA Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Omega-3 PUFA Sales by Country (2021-2032)
- 5.5.3 Europe Omega-3 PUFA Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Omega-3 PUFA Market Facts & Figures by Country
- 5.6.1 Asia Pacific Omega-3 PUFA Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Omega-3 PUFA Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Omega-3 PUFA Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Omega-3 PUFA Market Facts & Figures by Country
- 5.7.1 South America Omega-3 PUFA Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Omega-3 PUFA Sales by Country (2021-2032)
- 5.7.3 South America Omega-3 PUFA Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Omega-3 PUFA Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Omega-3 PUFA Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Omega-3 PUFA Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Omega-3 PUFA Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Omega-3 PUFA Sales by Type (2021-2032)
- 6.1.1 Global Omega-3 PUFA Sales by Type (2021-2032) & (t)
- 6.1.2 Global Omega-3 PUFA Sales Market Share by Type (2021-2032)
- 6.2 Global Omega-3 PUFA Revenue by Type (2021-2032)
- 6.2.1 Global Omega-3 PUFA Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Omega-3 PUFA Revenue Market Share by Type (2021-2032)
- 6.3 Global Omega-3 PUFA Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Omega-3 PUFA Sales by Application (2021-2032)
- 7.1.1 Global Omega-3 PUFA Sales by Application (2021-2032) & (t)
- 7.1.2 Global Omega-3 PUFA Sales Market Share by Application (2021-2032)
- 7.2 Global Omega-3 PUFA Revenue by Application (2021-2032)
- 7.2.1 Global Omega-3 PUFA Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Omega-3 PUFA Revenue Market Share by Application (2021-2032)
- 7.3 Global Omega-3 PUFA Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Omega-3 PUFA Value Chain Analysis
- 8.1.1 Omega-3 PUFA Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Omega-3 PUFA Production Mode & Process
- 8.2 Omega-3 PUFA Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Omega-3 PUFA Distributors
- 8.2.3 Omega-3 PUFA Customers
9 Global Omega-3 PUFA Analyzing Market Dynamics
- 9.1 Omega-3 PUFA Industry Trends
- 9.2 Omega-3 PUFA Industry Drivers
- 9.3 Omega-3 PUFA Industry Opportunities and Challenges
- 9.4 Omega-3 PUFA Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst